Award recordCONTRACT

UNITED THERAPEUTICS CORP

PIID VA757A10058· VHA· 757-COLUMBUS· 6505 · DRUGS AND BIOLOGICALS· FY2011· $110,815 net obligations· UEI KK5FBFA43JS7· MD

Description

FLOLAN AND REMODULIN

First action · last action
2010-12-01 · 2011-02-22
Transactions
4
First transaction's obligation
$18,469
Base + all options value (sum of deltas)
$221,629
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
Parent IDV
V797P5096B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$110,815$0Base award · 2010-12-01 · this action $18,469 · running total $18,469Modification 1 · 2010-12-21 · this action $36,938 · running total $55,407Modification 2 · 2011-01-07 · this action $36,938 · running total $92,346Modification 3 · 2011-02-22 · this action $18,469 · running total $110,815
  • Base2010-12-01+$18,469= $18,469
  • Mod 12010-12-21+$36,938= $55,407
  • Mod 22011-01-07+$36,938= $92,346
  • Mod 32011-02-22+$18,469= $110,815
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2010-12-01+$18,469$18,469FLOLAN AND REMODULIN
Mod 1· FUNDING ONLY ACTION2010-12-21+$36,938$55,407FLOLAN AND REMODULIN
Mod 2· FUNDING ONLY ACTION2011-01-07+$36,938$92,346FLOLAN AND REMODULIN
Mod 3· FUNDING ONLY ACTION2011-02-22+$18,469$110,815FLOLAN AND REMODULIN

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KK5FBFA43JS7)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0777245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,158FY2026
36C24526N0755245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0754245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24526N0723245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0722245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0707245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026

Other recipients under 6505 from 757-COLUMBUS (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25012P0965CARDINAL HEALTH 414, LLC757-COLUMBUS$28,554FY2012
VA25012P0967TRIAD ISOTOPES, INC.757-COLUMBUS$21,171FY2012
VA25012P0841CARDINAL HEALTH 414, LLC757-COLUMBUS$7,427FY2012
VA25012P0839TRIAD ISOTOPES, INC.757-COLUMBUS$7,020FY2012
VA25012F0662CARDINAL HEALTH 414, INC.757-COLUMBUS$13,906FY2012

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA757A10058_3600_V797P5096B_3600 · retrieved 2026-09-26.